No Data
No Data
AbbVie Inc. (NYSE:ABBV) Is Largely Controlled by Institutional Shareholders Who Own 73% of the Company
Trending Stocks This Week as U.S. Equities Notch Their Best Week of 2024
These 10 Drugs Will Be Cheaper After Medicare Negotiations
10 Health Care Stocks With Whale Alerts In Today's Session
Express News | AbbVie Announces EPKINLY Listing On Ontario Health (Cancer Care Ontario) Formulary And Quebec's RAMQ For Treatment Of Relapsed Or Refractory Diffuse Large B-Cell Lymphoma In Adult Patients After Two Or More Lines Of Therapy
Express News | Abbvie Announces Ontario and Quebec Are First Provinces to Reimburse Subcutaneous Epkinly™ (Epcoritamab) for the Treatment of Diffuse Large B-Cell Lymphoma Under New Early Access Process
loading...